Bladder Cancer - Results from #440

Dysregulation of mTOR pathway in plasmacytoid variant of urothelial carcinoma of the urinary bladder, "Beyond the Abstract," by Nilda D. Gonzalez-Roibon and George J. Netto, MD July 23, 2013

Prognosis and local control rate following sequential chemoradiation for small cell carcinoma of the bladder, "Beyond the Abstract," by R.P. Meijer, MD, FEBU and A. Bex, MD, PhD May 21, 2013

Ethnicity and smoking status are associated with awareness of smoking related genitourinary diseases, "Beyond the Abstract," by Lindsay Lombardo, DO and Courtney M. P. Hollowell, MD, FACS May 3, 2013

Bladder cancer in an inguinoscrotal vesical hernia, "Beyond the Abstract," by Lucas Regis, et al April 22, 2013

CK5, CK5/6, and double-stains CK7/CK5 and p53/CK5 discriminate in situ vs invasive urothelial cancer in the prostate, "Beyond the Abstract," by Eric J. Fichtenbaum, BS, and Debra L. Zynger, MS, MD March 22, 2013

Clinical management of small-cell carcinoma of the urinary tract: A 10-year single-center's experience, "Beyond the Abstract," by Ignacio Gil-Bazo, MD, PhD March 15, 2013

Current role of radiation therapy for bladder cancer, "Beyond the Abstract," by Howard M. Sandler, MD and Amin J. Mirhadi, MD March 15, 2013

Extravasation of intravesical chemotherapy for non-muscle-invasive bladder cancer, "Beyond the Abstract," by Laura S. Mertens, et al February 28, 2013

Intravesical delivery of small activating RNA formulated into lipid nanoparticles inhibits orthotopic bladder tumor growth, "Beyond the Abstract," by Glen Yang, MD and Long-Cheng Li, MD February 27, 2013

Characterization of urine-derived cells from upper urinary tract in patients with bladder cancer, "Beyond the Abstract," by Hyun Tae Kim, MD and Tae Gyun Kwon, MD, PhD January 31, 2013

Update on the management of invasive bladder cancer 2012, "Beyond the Abstract," by Prof. Dr. H. Van Poppel January 19, 2013

Alloplastic bladder substitution: Are we making progress? "Beyond the Abstract," by Marco Cosentino, MD, FEBU January 9, 2013

Lenalidomide augments the efficacy of bacillus Calmette-Guerin (BCG) immunotherapy in vivo, "Beyond the Abstract," by Goodwin Jinesh G., PhD and Ashish M. Kamat, MD January 7, 2013

Narrow-band imaging cystoscopy in non-muscle-invasive bladder cancer: A prospective comparison to the standard approach, "Beyond the Abstract," by Bogdan Geavlete, MD, PhD January 3, 2013

Use of cystoscopic tattooing in laparoscopic partial cystectomy, "Beyond the Abstract," by Youn Soo Jeon, MD, PhD December 7, 2012

Reactive arthritis after the intravesical instillation of BCG, "Beyond the Abstract," by Cristina Clara Macía Villa and Walter Alberto Sifuentes Giraldo December 4, 2012

Alvimopan provides rapid gastrointestinal recovery without nasogastric tube decompression after radical cystectomy and urinary diversion, "Beyond the Abstract," by Anup Vora, MD and Mohan Verghese, MD November 28, 2012

Comparative effectiveness of imaging modalities for the diagnosis of upper and lower urinary tract malignancy: A critically appraised topic, "Beyond the Abstract," by Seyed Amirhossein Razavi, MD, et al November 27, 2012

The role of the androgen receptor in the development and progression of bladder cancer, "Beyond the Abstract," by Hiroshi Miyamoto, MD, PhD November 23, 2012

Bradeion (SEPT4) as a urinary marker of transitional cell bladder cancer: A real-time polymerase chain reaction study of gene expression, "Beyond the Abstract," by Luca Bongiovanni MD, PhD November 21, 2012

Page 23 of 26